GLP-1 Medicare Coverage 2026: Does Medicare Pay for Wegovy & Zepbound?

The big change: Medicare now covers GLP-1s

For years, Medicare was barred by law from covering weight loss medications. That changed. Starting in 2026, Medicare Part D now covers FDA-approved anti-obesity medications, including Wegovy (semaglutide) and Zepbound (tirzepatide). This is a game-changer for millions of Medicare beneficiaries who previously had to pay $1,000+ per month out of pocket.

If you are on Medicare and have been considering GLP-1 treatment, check your eligibility with a US telehealth provider to see if you qualify for coverage.

What Medicare covers in 2026

Medication	Covered by Medicare Part D?	Estimated Copay (with Bridge)	Estimated Copay (without Bridge)
Wegovy (semaglutide)	Yes	$50/month	$200 to $600+/month
Zepbound (tirzepatide)	Yes	$50/month	$200 to $600+/month
Ozempic (semaglutide, T2D)	Yes (for T2D only)	Varies by plan	$25 to $300/month
Mounjaro (tirzepatide, T2D)	Yes (for T2D only)	Varies by plan	$25 to $300/month
Compounded GLP-1	No	N/A (cash pay)	$200 to $500/month
Check if Medicare covers your GLP-1

See if you qualify for $50/month GLP-1

The Medicare GLP-1 Bridge program

Effective July 1, 2026, the Medicare GLP-1 Bridge program provides reduced-cost access to FDA-approved weight loss medications for eligible Part D beneficiaries. Key details:

Cost: As low as $50 per month for eligible LIS beneficiaries
Medications: Wegovy, Zepbound, and other FDA-approved anti-obesity drugs
Eligibility: Enrolled in Medicare Part D with qualifying BMI
Requirements: Valid prescription from a licensed provider
Enrollment: Automatic for qualifying LIS beneficiaries; others may need to apply

How to get GLP-1 covered by Medicare: step by step

Step	Action	What You Need
1	Check your Part D plan formulary	Medicare plan name, member ID
2	Get a prescription from a licensed provider	Medical history, BMI documentation
3	Submit prior authorization if required	Provider completes PA paperwork
4	Apply for the Bridge program if eligible	Proof of Part D enrollment, LIS status
5	Fill prescription at in-network pharmacy	Insurance card, prescription
Start the process with a provider

Medicare Advantage and GLP-1 coverage

Medicare Advantage (Part C) plans with prescription drug coverage (MA-PD) may also cover GLP-1 medications. Coverage varies by plan:

Some MA-PD plans offer enhanced drug benefits that reduce GLP-1 copays
Plans may require step therapy (trying other medications first)
Prior authorization is commonly required
Check your plan's formulary or call the number on your insurance card
Annual enrollment periods allow switching to a plan with better GLP-1 coverage

Compare your coverage options

Medicare vs cash pay: which is cheaper?

Option	Monthly Cost	Pros	Cons
Medicare Bridge (LIS)	$50	Lowest cost, brand-name medication	Must qualify for LIS
Medicare Part D (standard)	$200 to $600+	Brand-name, FDA-approved	High copay, PA may be needed
Compounded (cash pay)	$200 to $500	No insurance needed, fast access	Not covered by Medicare
Manufacturer savings card	$25 to $500	Can reduce brand-name cost	Not valid for Medicare patients (federal law)
Find the cheapest option for you

Important note about manufacturer coupons

Federal law prohibits the use of manufacturer savings cards (like the Wegovy or Zepbound savings cards) for patients on Medicare or Medicaid. If you are on Medicare, you cannot use these coupons. The Bridge program and your Part D plan are your best options for reducing costs.

Understanding Medicare Part D formulary tiers

GLP-1 medications are typically placed on higher formulary tiers, which means higher copays. Understanding how tiers work helps you predict your costs:

Tier	Typical Medications	GLP-1 Placement	Estimated Copay
Tier 1 (Preferred Generic)	Generic drugs	N/A	$1 to $10
Tier 2 (Non-Preferred Generic)	Less common generics	N/A	$10 to $20
Tier 3 (Preferred Brand)	Common brand-name drugs	Sometimes (Ozempic for T2D)	$25 to $50
Tier 4 (Non-Preferred Brand)	Higher-cost brands	Wegovy, Zepbound often here	$45 to $100+
Tier 5 (Specialty)	High-cost specialty drugs	Some plans place GLP-1s here	$100 to $600+ (33% coinsurance)
Check your plan's tier placement

Prior authorization: what it is and how to navigate it

Most Medicare Part D plans require prior authorization (PA) before covering GLP-1 medications. This means your provider must prove medical necessity before the plan will pay. Here is how to navigate the process:

Step	Action	Who Does It	Timeline
1	Provider submits PA request with medical records	Your prescribing provider	1 to 3 days
2	Plan reviews PA request	Insurance plan	3 to 5 business days (standard), 72 hours (expedited)
3	Approval or denial	Insurance plan	Notification by mail or phone
4	If denied: file appeal (Redetermination)	You or your provider	Within 60 days of denial
5	Plan reconsiders appeal	Insurance plan	7 days (standard), 72 hours (expedited)
6	If still denied: escalate to Independent Review Entity	You or your provider	Within 60 days
Get help with prior authorization

What documentation helps with PA approval

BMI documentation showing 30+ (or 27+ with comorbidity)
Documented weight-related conditions: hypertension, T2D, sleep apnea, dyslipidemia
Previous weight loss attempts (diet, exercise, other medications tried)
Provider's clinical justification for GLP-1 specifically
For T2D patients: HbA1c levels and current diabetes management

Connect with a provider who handles PA

Medicaid and GLP-1 coverage

Medicaid coverage for GLP-1 medications varies significantly by state. Here is a general overview:

State Category	T2D Coverage	Weight Loss Coverage	Notes
Generous states (CA, NY, MA)	Yes	Often yes with PA	Cover Wegovy/Zepbound for obesity
Moderate states (TX, FL, IL)	Yes	Limited, case-by-case	May require step therapy
Restrictive states	Yes (usually)	Rarely	T2D only; weight loss often excluded
All states	Ozempic/Mounjaro for T2D	Varies widely	Check with your state Medicaid office

Enrollment periods: when to switch plans

If your current Medicare plan does not cover GLP-1s well, you can switch during these enrollment periods:

Period	Dates	What You Can Do
Annual Enrollment Period (AEP)	Oct 15 to Dec 7	Switch Part D or MA-PD plans
Open Enrollment for MA-PD	Jan 1 to Mar 31	Switch MA plans or return to Original Medicare
Special Enrollment Period (SEP)	Anytime (qualifying events)	Switch if you move, lose coverage, or qualify for LIS
Initial Enrollment Period	7 months around your 65th birthday	First chance to enroll in Medicare
Compare plans during enrollment

Tips for maximizing Medicare GLP-1 coverage

Compare formularies annually: Plans change their drug lists every year. A plan that covered GLP-1s well last year may not this year.
Check tier placement: Lower tiers mean lower copays. Look for plans that place Wegovy or Zepbound on Tier 3 or 4 rather than Tier 5.
Apply for LIS if eligible: Low-Income Subsidy can dramatically reduce your copays and qualify you for the Bridge program.
Use telehealth for prescriptions: Online providers can prescribe and help with PA paperwork, often faster than in-person doctors.
Keep documentation: Maintain records of your BMI, weight-related conditions, and previous weight loss attempts to support PA requests.
Appeal denials: Many PA denials are overturned on appeal. Don't give up after the first denial.
Consider Medicare Advantage: Some MA-PD plans offer enhanced drug benefits that reduce GLP-1 copays.
Plan for the donut hole: The coverage gap (donut hole) is closing, but you may still see cost changes mid-year. Budget accordingly.

Maximize my Medicare GLP-1 coverage

Frequently asked questions

Does Medicare cover GLP-1 medications in 2026?

Yes. Starting in 2026, Medicare Part D covers FDA-approved anti-obesity medications including Wegovy and Zepbound. Low-Income Subsidy (LIS) beneficiaries pay a maximum of $50 per month. Medicare Advantage plans with enhanced drug benefits may also cover these medications.

How much does Wegovy cost on Medicare?

With the Medicare GLP-1 Bridge program effective July 1, 2026, eligible beneficiaries pay as little as $50 per month for Wegovy or Zepbound. Without the Bridge program, standard Part D copays vary by plan and can range from $200 to $600+ per month.

Can I get compounded GLP-1 through Medicare?

No. Medicare does not cover compounded medications. Compounded GLP-1s are cash-pay only. However, they may still be cheaper than Medicare copays for brand-name medications in some cases.

How do I qualify for the Medicare GLP-1 Bridge program?

You must be enrolled in Medicare Part D, have a qualifying BMI (30+ or 27+ with a weight-related condition), and have a prescription from a licensed provider. Your provider can help determine if you meet the criteria.

Can I use a manufacturer savings card with Medicare?

No. Federal law prohibits the use of manufacturer savings cards (like Wegovy or Zepbound savings cards) for patients on Medicare or Medicaid. The Bridge program and your Part D plan are your best options for reducing costs.

Does Medicaid cover GLP-1 medications?

Medicaid coverage for GLP-1 medications varies by state. Many states cover FDA-approved GLP-1s for type 2 diabetes but not for weight loss alone. Check with your state Medicaid office for specific coverage details.

What if my Medicare plan denies coverage for GLP-1?

You can appeal. Ask your provider to submit a prior authorization with supporting medical documentation. If denied, you can file a formal appeal through your Part D plan. Many denials are overturned on appeal when proper documentation is provided.

Can I switch Medicare plans to get better GLP-1 coverage?

Yes. During the Annual Enrollment Period (October 15 to December 7), you can switch to a Part D or Medicare Advantage plan with better GLP-1 coverage. Compare formularies and copays before switching.

Get started with a Medicare-covered GLP-1 plan

Conclusion

Medicare coverage for GLP-1 medications in 2026 is a landmark change. With the Bridge program offering $50/month access for eligible beneficiaries, millions of Americans on Medicare can now afford Wegovy or Zepbound. If you are on Medicare, check your Part D formulary, talk to a provider about getting a prescription, and apply for the Bridge program if you qualify. If Medicare coverage is not an option, compounded GLP-1 programs from telehealth providers remain an affordable alternative.